Biotech titan Roche acquired Boston, Mass.-based medical device company Constitutional Medical Investors for a reported $220 million plus possible milestones.
Women's Health
Women’s health: Smith & Nephew win over Hologic stands, damages TBD
Pelvic mesh lawsuits: Internal Bard memo shows medical device company knew mesh was unfit for humans
Mirabilis Medica pulls in $13M Series A round for ultrasound fibroid device
Mirabilis Medica said it raised up to $13 million in a Series A1 round and tapped a new CEO to lead the development of its ultrasound treatment for uterine fibroids.
The Bothell, Wash.-based medical device company said it closed on an initial $7 million round led by GSR Ventures, including $4 million in cash and a $3 million conversion of debt to equity. Charter Life Sciences also participated in the round.
Breast implants: FDA approves Mentor’s MemoryShape
After more than a year on the market outside the U.S., FDA regulators approved Johnson & Johnson (NYSE:JNJ) subsidiary Mentor’s MemoryShape breast implants, shaped more like a teardrop than the traditional round implants.
TEI Biosciences launches U.S. trial for breast reconstruction surgery device
Waltham, Mass.-based TEI Biosciences won the FDA’s green light to launch a U.S. clinical trial evaluating its breast reconstruction device in women who have undergone a mastectomy.
Women’s health: Swedish regulators recommend preventative removal of PIP breast implants
It’s more bad news for women who received breast enlargement or reconstruction with implants manufactured by French medical device maker Poly Implant Prothèse, as healthcare regulators in Sweden recommended this week that all patients undergo preventative removal of the devices, even those with no indications of problems with the implants.
Mastectomies: Could Cohera device have helped Angelina Jolie recover more quickly?
Cohera Medical said it completed a series of mastectomies in Germany using its TissuGlu surgical adhesive, which the medical device company hopes will eventually eliminate the need for drain placement and ease the healing process for patients who have their breast tissue removed.
Hologic slips on missed Q2 revenues, lowered outlook
Boston Scientific leads $9.7M Series B round for Channel Medsystems
Massachusetts-based medical device industry giant Boston Scientific (NYSE:BSX) led investment in the latest funding round for Channel Medsystems, a clinical-stage cryoablation delivery systems maker.